2023 Pancreatic Diseases Gordon Research Conference and Gordon Research Seminar
2023年胰腺疾病戈登研究大会暨戈登研究研讨会
基本信息
- 批准号:10681581
- 负责人:
- 金额:$ 0.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-28 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Acinar CellAddressAlpha CellAreaAutoimmuneBiologicalBiological AssayBiologyCell CommunicationCell TherapyCell secretionCellsClinicalCollaborationsCommunicationCommunitiesDataDedicationsDevelopmentDiabetes MellitusDigestionDisciplineDiseaseDisparateDuctal Epithelial CellDuodenumEndocrineEndocrinologistEnvironmentEnzymesExocrine pancreasFellowshipFemaleFoodFosteringFunctional disorderGastroenterologistGene Expression RegulationGenerationsGeneticGenomicsGlucagonGlucoseGoalsHealthHealth systemHomeostasisHormonesHumanImageImmune systemImpairmentIn VitroInsulinInterdisciplinary StudyInternationalIslet CellIslets of LangerhansItalyLifeLinkMaintenanceMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of pancreasMediatingMedicalMentorsMentorshipMetabolicModelingMolecularMusNatural regenerationOralOrganOrganoidsPancreasPancreatic AdenocarcinomaPancreatic DiseasesPancreatitisPhysiologicalPositioning AttributePostdoctoral FellowPreventionProcessResearchResearch PersonnelResolutionRisk FactorsRoleScientistSomatostatinStructure of beta Cell of isletStudentsSurgeonTimeTrainingUnderrepresented MinorityUnderrepresented PopulationsWorkWorkplacecareercareer developmentcell behaviorcell typechronic pancreatitiscomorbiditycomputerized toolsdesigndiversity and inclusionempowermentepidemiology studyexosomeextracellular vesicleshuman diseaseinsightinterdisciplinary approachisletlecturesmeetingsmicrobiomeminority investigatornovelnovel strategiespancreas developmentpancreatic cancer modelpancreatic cancer patientspancreatic juicepeerpharmacologicpostersprogramsrecruitresponsesymposiumtooltranslational approach
项目摘要
PROJECT SUMMARY
Gordon Research Conferences (GRCs) are a group of prestigious, non-profit, international scientific conferences
that have been held since 1931. This R13 proposal relates to the GRC on Pancreatic Diseases: "Pancreatic
Diseases: Understanding cell behavior and communication” and the associated trainee-led Gordon Research
Seminar (GRS), held April 29 - May 5, 2023, in Lucca, Italy. Recent years have brought rapid advances in our
understanding of the molecular mechanisms underlying pancreatic development, regeneration, and malignant
transformation, as well as our ability to model these processes in mice and human cells. These studies have
revealed lineage relationships between the different pancreatic cell types and plasticity in response to
environmental influences. Moreover, epidemiological studies show a clear association between pancreatic
diseases, in particular between diabetes and pancreatic cancer. Yet, the mechanisms involved in the co-
occurrence of pancreatic diseases are poorly understood. This GRC aims to link the understanding of the biology
of the exocrine and endocrine pancreas to applications for human diseases. This conference is unique in that it
convenes experts from all aspects of pancreas biology as well as clinicians working on translational approaches
for diabetes, pancreatic cancer and pancreatitis. By providing a forum for the presentation and discussion of
cutting edge, unpublished concepts and approaches, the goal of this GRC is to stimulate discussion across
disciplines. This exchange will foster interdisciplinary approaches and promote exchange of ideas to lead to new
collaborations, as well as empower young scientists to showcase their work to peers and leaders in the field.
The upcoming, fifth Pancreatic Diseases GRC will focus on understanding cell behavior and communication in
pancreatic diseases with the goal of gaining insights into how the systemic and local environment impact
endocrine and exocrine cells in health and disease. The program that has been assembled is first-rate,
benefitting from the contribution of international world-class scientists engaged in research relevant to different
aspects of pancreatic diseases. The ultimate goal of the conference is the identification of novel concepts in
pancreatic diseases that might be exploitable for pharmacological and cell-based therapeutic approaches. As
for all GRCs, the guiding principle of this conference is the presentation of new, unpublished results and the free,
unhampered discussion that follows. Participation of young scientists is especially emphasized, with
opportunities of short talks and poster presentations. To further enhance career development opportunities, a
Gordon Research Seminar (GRS) has been integrated into this meeting. Taking place immediately prior to the
GRC proper, the GRS features posters and talks exclusively by trainees as well as mentorship sessions designed
to provide trainees with established mentors willing to help guide their careers. Together, this makes for a rare
platform to promote young researchers, integrate trainees into the interdisciplinary pancreatic disease research
community, and impact their career trajectory at a critical time in their training.
项目摘要
戈登研究会议(GRC)是一组著名的,非营利的,国际科学会议
自1931年以来一直举行。本R13提案涉及胰腺疾病GRC:“胰腺
疾病:了解细胞行为和通信”和相关的受训者领导的戈登研究
研讨会(GRS),于2023年4月29日至5月5日在卢卡,意大利举行。近年来,我们的技术发展迅速,
了解胰腺发育、再生和恶性肿瘤的分子机制
转化,以及我们在小鼠和人类细胞中模拟这些过程的能力。这些研究
揭示了不同胰腺细胞类型之间的谱系关系,以及
环境影响。此外,流行病学研究表明,胰腺癌与糖尿病之间存在明显的相关性。
疾病,特别是糖尿病和胰腺癌之间。然而,参与合作的机制-
对胰腺疾病的发生知之甚少。本研究旨在将生物学的理解与
外分泌和内分泌胰腺的应用于人类疾病。本次会议的独特之处在于,
召集来自胰腺生物学各个方面的专家以及致力于转化方法的临床医生
治疗糖尿病、胰腺癌和胰腺炎。通过提供一个论坛,
前沿的,未发表的概念和方法,本GRC的目标是激发讨论,
学科这种交流将促进跨学科的方法,促进思想交流,
这将有助于促进合作,并使年轻科学家能够向该领域的同行和领导者展示他们的工作。
即将到来的第五届胰腺疾病GRC将专注于了解细胞行为和通信,
胰腺疾病,目的是深入了解系统和局部环境如何影响
内分泌和外分泌细胞的健康和疾病。已经组装的程序是一流的,
受益于国际世界级科学家的贡献,他们从事与不同领域有关的研究,
胰腺疾病的各个方面。会议的最终目标是确定新的概念,
胰腺疾病,可能是利用药理学和细胞为基础的治疗方法。作为
对于所有GRCs,本次会议的指导原则是介绍新的,未发表的结果和免费的,
不受阻碍的讨论。特别强调青年科学家的参与,
简短的演讲和海报展示的机会。为进一步增加职业发展机会,
戈登研究研讨会(GRS)已被纳入本次会议。发生在
在GRC本身,GRS的特色是由学员专门制作的海报和讲座,以及设计的导师课程
为学员提供愿意帮助指导其职业生涯的知名导师。总之,这使得一个罕见的
促进年轻研究人员的平台,将学员纳入跨学科胰腺疾病研究
社区,并在他们的培训的关键时刻影响他们的职业轨迹。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NABEEL El-BARDEESY其他文献
NABEEL El-BARDEESY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NABEEL El-BARDEESY', 18)}}的其他基金
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
Lin28b 在胰腺癌进展中作用的机制理解
- 批准号:
10558954 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
Lin28b 在胰腺癌进展中作用的机制理解
- 批准号:
10338071 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
Lin28b 在胰腺癌进展中作用的机制理解
- 批准号:
10559707 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
Lin28b 在胰腺癌进展中作用的机制理解
- 批准号:
10738337 - 财政年份:2019
- 资助金额:
$ 0.6万 - 项目类别:
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
针对 LKB1 突变肿瘤的新治疗漏洞。
- 批准号:
10443802 - 财政年份:2018
- 资助金额:
$ 0.6万 - 项目类别:
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
LKB1肿瘤抑制因子在代谢和表观遗传学控制中的功能
- 批准号:
10524240 - 财政年份:2018
- 资助金额:
$ 0.6万 - 项目类别:
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
LKB1肿瘤抑制因子在代谢和表观遗传学控制中的功能
- 批准号:
10337194 - 财政年份:2018
- 资助金额:
$ 0.6万 - 项目类别:
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
LKB1肿瘤抑制因子在代谢和表观遗传学控制中的功能
- 批准号:
10083201 - 财政年份:2018
- 资助金额:
$ 0.6万 - 项目类别:
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
针对 LKB1 突变肿瘤的新治疗漏洞。
- 批准号:
10208803 - 财政年份:2018
- 资助金额:
$ 0.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 0.6万 - 项目类别:
Research Grant














{{item.name}}会员




